84 related articles for article (PubMed ID: 29467935)
1. A robust gene expression-based prognostic risk score predicts overall survival of lung adenocarcinoma patients.
Chen EG; Wang P; Lou H; Wang Y; Yan H; Bi L; Liu L; Li B; Snijders AM; Mao JH; Hang B
Oncotarget; 2018 Jan; 9(6):6862-6871. PubMed ID: 29467935
[TBL] [Abstract][Full Text] [Related]
2. A Robust Gene Expression Prognostic Signature for Overall Survival in High-Grade Serous Ovarian Cancer.
Zhao Y; Yang SM; Jin YL; Xiong GW; Wang P; Snijders AM; Mao JH; Zhang XW; Hang B
J Oncol; 2019; 2019():3614207. PubMed ID: 31885574
[TBL] [Abstract][Full Text] [Related]
3. A novel gene expression-based prognostic scoring system to predict survival in gastric cancer.
Wang P; Wang Y; Hang B; Zou X; Mao JH
Oncotarget; 2016 Aug; 7(34):55343-55351. PubMed ID: 27419373
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide screen identifies a novel prognostic signature for breast cancer survival.
Mao XY; Lee MJ; Zhu J; Zhu C; Law SM; Snijders AM
Oncotarget; 2017 Feb; 8(8):14003-14016. PubMed ID: 28122328
[TBL] [Abstract][Full Text] [Related]
5. A potential signature of eight long non-coding RNAs predicts survival in patients with non-small cell lung cancer.
Zhou M; Guo M; He D; Wang X; Cui Y; Yang H; Hao D; Sun J
J Transl Med; 2015 Jul; 13():231. PubMed ID: 26183581
[TBL] [Abstract][Full Text] [Related]
6. A robust prognostic gene expression signature for early stage lung adenocarcinoma.
Krzystanek M; Moldvay J; Szüts D; Szallasi Z; Eklund AC
Biomark Res; 2016; 4():4. PubMed ID: 26900477
[TBL] [Abstract][Full Text] [Related]
7. Identification and validation of potential prognostic lncRNA biomarkers for predicting survival in patients with multiple myeloma.
Zhou M; Zhao H; Wang Z; Cheng L; Yang L; Shi H; Yang H; Sun J
J Exp Clin Cancer Res; 2015 Sep; 34(1):102. PubMed ID: 26362431
[TBL] [Abstract][Full Text] [Related]
8. A novel seven-long non-coding RNA signature predicts survival in early stage lung adenocarcinoma.
Chen M; Liu B; Xiao J; Yang Y; Zhang Y
Oncotarget; 2017 Feb; 8(9):14876-14886. PubMed ID: 28122330
[TBL] [Abstract][Full Text] [Related]
9. Gene expression signature-based prognostic risk score in patients with primary central nervous system lymphoma.
Kawaguchi A; Iwadate Y; Komohara Y; Sano M; Kajiwara K; Yajima N; Tsuchiya N; Homma J; Aoki H; Kobayashi T; Sakai Y; Hondoh H; Fujii Y; Kakuma T; Yamanaka R
Clin Cancer Res; 2012 Oct; 18(20):5672-81. PubMed ID: 22908096
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Fifteen-Gene Signature for Early Stage Pancreatic Ductal Adenocarcinoma.
Chen DT; Davis-Yadley AH; Huang PY; Husain K; Centeno BA; Permuth-Wey J; Pimiento JM; Malafa M
PLoS One; 2015; 10(8):e0133562. PubMed ID: 26247463
[TBL] [Abstract][Full Text] [Related]
11. Gene expression signature predicts recurrence in lung adenocarcinoma.
Larsen JE; Pavey SJ; Passmore LH; Bowman RV; Hayward NK; Fong KM
Clin Cancer Res; 2007 May; 13(10):2946-54. PubMed ID: 17504995
[TBL] [Abstract][Full Text] [Related]
12. Integrative analysis of multi-omics data reveals distinct impacts of DDB1-CUL4 associated factors in human lung adenocarcinomas.
Yan H; Bi L; Wang Y; Zhang X; Hou Z; Wang Q; Snijders AM; Mao JH
Sci Rep; 2017 Mar; 7(1):333. PubMed ID: 28336923
[TBL] [Abstract][Full Text] [Related]
13. Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer.
Krishnan P; Ghosh S; Wang B; Li D; Narasimhan A; Berendt R; Graham K; Mackey JR; Kovalchuk O; Damaraju S
BMC Genomics; 2015 Sep; 16():735. PubMed ID: 26416693
[TBL] [Abstract][Full Text] [Related]
14. A seven-gene signature predicts overall survival of patients with colorectal cancer.
Chen H; Sun X; Ge W; Qian Y; Bai R; Zheng S
Oncotarget; 2017 Nov; 8(56):95054-95065. PubMed ID: 29221110
[TBL] [Abstract][Full Text] [Related]
15. A prognostic test for adenocarcinoma of the lung from gene expression profiling data.
Gordon GJ; Richards WG; Sugarbaker DJ; Jaklitsch MT; Bueno R
Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):905-10. PubMed ID: 14504202
[TBL] [Abstract][Full Text] [Related]
16. Use of a cytokine gene expression signature in lung adenocarcinoma and the surrounding tissue as a prognostic classifier.
Seike M; Yanaihara N; Bowman ED; Zanetti KA; Budhu A; Kumamoto K; Mechanic LE; Matsumoto S; Yokota J; Shibata T; Sugimura H; Gemma A; Kudoh S; Wang XW; Harris CC
J Natl Cancer Inst; 2007 Aug; 99(16):1257-69. PubMed ID: 17686824
[TBL] [Abstract][Full Text] [Related]
17. A long non-coding RNA expression signature to predict survival of patients with colon adenocarcinoma.
Xue W; Li J; Wang F; Han P; Liu Y; Cui B
Oncotarget; 2017 Nov; 8(60):101298-101308. PubMed ID: 29254165
[TBL] [Abstract][Full Text] [Related]
18. Consensus of gene expression phenotypes and prognostic risk predictors in primary lung adenocarcinoma.
Ringnér M; Staaf J
Oncotarget; 2016 Aug; 7(33):52957-52973. PubMed ID: 27437773
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling-derived immunohistochemistry signature with high prognostic value in colorectal carcinoma.
Chang W; Gao X; Han Y; Du Y; Liu Q; Wang L; Tan X; Zhang Q; Liu Y; Zhu Y; Yu Y; Fan X; Zhang H; Zhou W; Wang J; Fu C; Cao G
Gut; 2014 Sep; 63(9):1457-67. PubMed ID: 24173294
[TBL] [Abstract][Full Text] [Related]
20. Identification and Construction of Combinatory Cancer Hallmark-Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer.
Gao S; Tibiche C; Zou J; Zaman N; Trifiro M; O'Connor-McCourt M; Wang E
JAMA Oncol; 2016 Jan; 2(1):37-45. PubMed ID: 26502222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
